Mental Health
News Category
New Study Identifies Key Pathway Driving Spinal Scarring, Offers Potential Therapeutic Targets
Researchers discovered the c-Jun–Irf8–CD36 signaling axis promotes fibrotic scarring after spinal cord injury, and targeting CD36 or c-Jun reduces sca...
Antibody Therapeutics Sector Deal Activity Highlights Value for VERAXA Biotech (VRXA) Shareholders
The article discusses how strategic licensing agreements and acquisitions in antibody therapeutics, particularly ADCs and T-cell engagers, create earl...
Quantum BioPharma CEO Discusses Lucid-MS Strategy and unbuzzd Progress on BioMedWire Podcast
Quantum BioPharma executive co-chair Anthony Durkacz detailed the company's multiple sclerosis drug candidate Lucid-MS and its alcohol metabolism acce...
Quantum BioPharma Details MS Drug Candidate and Growth Strategy in Executive Podcast
Quantum BioPharma's executive co-chairman Anthony Durkacz discussed the company's lead multiple sclerosis drug candidate Lucid-MS and its alcohol meta...
Onco-Innovations Advances ONC010 Manufacturing Development With Nanosoft
Onco-Innovations Limited announced the initiation of polymer process development and analytical characterization by Nanosoft Polymers to support the s...
Annovis Bio Promotes Cheng Fang to Chief Scientific Officer as Phase 3 Alzheimer's Study Nears Data
Annovis Bio promoted Cheng Fang to chief scientific officer to lead scientific strategy as the company advances buntanetap toward Phase 3 Alzheimer's ...
GeoVax Highlights U.S. Government Investment in Orthopox Preparedness as Validation of Long-Term Vaccine Readiness
GeoVax comments on recent U.S. government procurement of ACAM2000 smallpox vaccine, reinforcing the strategic importance of sustained investment in or...
Next-Generation Precision Obesity Models Aim to Close Translational Gap in Anti-Obesity Drug Development
As obesity drug development shifts toward complex therapies like amylin analogues and gene editing, traditional preclinical models fall short; Prother...
Helix BioPharma Appoints General Counsel and VP of Clinical Operations Ahead of U.S. Listing
Helix BioPharma strengthens its executive team with Helen Middleton as General Counsel and David Browning as VP of Clinical Operations to support its ...
HeartBeam Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study
HeartBeam (NASDAQ: BEAT) has completed patient enrollment early in its ALIGN-ACS pilot study for heart attack detection using its 3D ECG technology, w...
Onco-Innovations Advances Manufacturing and Development of PNKP Inhibitors for Hard-to-Treat Cancers
Onco-Innovations Ltd. is advancing kilogram-scale production of its lead PNKP inhibitor ONC010 and partnering with Nanosoft Polymers to optimize drug ...
FDA-Approved Drug Shows Promise in Enhancing Immunotherapy for Rare Liver Cancer
Researchers at the University of Washington have discovered that an existing FDA-approved drug may boost immunotherapy efficacy against fibrolamellar ...
Silo Pharma Advances SPC-15 Intranasal PTSD Program With Device Robustness Study
Silo Pharma announced a robustness study for its SPC-15 intranasal PTSD treatment delivery system, supporting regulatory progress toward a Type C meet...
HeartBeam Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study
HeartBeam Inc. has completed patient enrollment in its ALIGN-ACS pilot study ahead of schedule, evaluating its 3D ECG system for heart attack detectio...
Creative Biolabs Expands Custom Oligosaccharide Synthesis and Glycan Characterization to Accelerate Drug Discovery
Creative Biolabs integrates advanced synthesis and analytical platforms to provide structurally validated oligosaccharides, reducing technical risks a...
Amerigo Scientific Launches High-Purity iPSC-Derived Cells to Accelerate Biomedical Research and Cell Therapy Development
Amerigo Scientific releases premium iPSC-derived cells and engineered reporter lines, providing robust tools for disease modeling, drug screening, and...
Ace Therapeutics Unveils Comprehensive Preclinical Pain Research Platform for Analgesic Drug Development
Ace Therapeutics announces a full-spectrum preclinical analgesic drug development service with diverse in vivo pain models and integrated research cap...
Lifespan Edge Expands Longevity Clinics to Florida and Maryland with Focus on Preventive Medicine and Plasma Exchange Research
Lifespan Edge, co-founded by futurist John Mauldin and Dr. Michael Roizen, opens new clinics in West Palm Beach and Columbia, advancing concierge-styl...
Quantum BioPharma Hits Midpoint Milestone in MS Imaging Study, Early Results Show Promise
Quantum BioPharma announced that its collaborative multiple sclerosis imaging study with Massachusetts General Hospital has reached the halfway point ...
Cardio Diagnostics Highlights Blind Spot in Coronary Heart Disease Detection
Cardio Diagnostics (CDIO) reports that traditional risk factors miss about 50% of coronary heart disease cases, emphasizing the need for molecular pre...
American Heart Association Funds $3.4 Million in Grants for Cardiac Arrest Research Teams in New York and Oregon
The American Heart Association is funding two multidisciplinary research teams with $3.4 million to improve cardiac arrest prediction, treatment, and ...
Oncotelic Therapeutics Publishes Peer-Reviewed Validation of Deciparticle Platform, Advancing Intravenous Delivery of Poorly Soluble Drugs
Oncotelic Therapeutics announced the publication of a peer-reviewed manuscript validating its Deciparticle nanoparticle platform, which enables intrav...
Helus Pharma Reports Fiscal 2026 Results, Phase 3 Trial on Track
Helus Pharma announced fiscal 2026 financial results and provided updates on its clinical pipeline, with its lead candidate HLP003 for major depressiv...
Tonix Pharmaceuticals Enrolls First Patient in Phase 2 Depression Trial, Targeting Unmet Need in MDD
Tonix Pharmaceuticals has enrolled the first patient in its HORIZON Phase 2 trial evaluating TNX-102 SL as a first-line monotherapy for major depressi...
Global Experts Update Heart Failure Definition to Improve Prevention, Diagnosis and Care
An international expert consensus document refines the definition and classification of heart failure, emphasizing early detection, individualized ris...
Cuts, Uncertainty Over NIH Grants Disrupt Innovation In Health Fields, Researchers Say
NIH grant cuts and reinstatements have disrupted research programs like UMD-REACH, slowing progress in health innovation and burdening researchers wit...
New Smart Pen Detects Parkinson's Disease with 96% Accuracy in Early Stages
UCLA researchers have developed a smart pen that detects early-stage Parkinson's disease with 96.22% accuracy, potentially enabling earlier treatment ...
Clene’s CNM-Au8 Shows Preclinical Promise in Restoring Cellular Health in Parkinson’s Disease
Clene Inc. presented new preclinical data for CNM-Au8, demonstrating improvements in mitochondrial health and metabolism in Parkinson’s disease models...
Creative Biolabs Launches Antibody Tools for Neuroscience Research
Creative Biolabs introduces new antibody products targeting GRID2, tyrosine hydroxylase, and ACTN3 to support research in synaptic function, neurotran...
Clene Presents Positive REPAIR-MS Results at ECTRIMS 2025, Showing CNM-Au8 Improves Brain Energy Metabolism in Multiple Sclerosis Patients
Clene Inc. announced at ECTRIMS 2025 that its investigational therapy CNM-Au8 significantly improved brain NAD+/NADH ratios in both relapsing and non-...
Menstrual Migraine: A Hidden Health Crisis for Women
Menstrual migraine attacks, driven by hormonal fluctuations, are often dismissed but can be debilitating; understanding their unique triggers and gene...
Tevard Biosciences Reports Full-Length Protein Rescue in DMD and DCM-TTNtv Models with Suppressor tRNA Therapy
New preclinical data show Tevard's suppressor tRNAs restore functional dystrophin and titin proteins, supporting clinical advancement for Duchenne mus...
GeoVax Endorses U.S. America First Global Health Strategy, Aligning Pipeline with National Security Priorities
GeoVax Labs supports the U.S. America First Global Health Strategy, highlighting how its vaccine pipeline—including Mpox/smallpox and COVID-19 vaccine...
TriNetX Named Among Top 25 Healthcare Software Companies of 2025
TriNetX has been recognized by The Healthcare Technology Report as one of the top 25 healthcare software companies of 2025, highlighting its leadershi...
Quantum BioPharma Reports 100% Approval of All Resolutions at Annual Meeting
Quantum BioPharma Ltd. announced that all resolutions at its annual general and special meeting were approved by shareholders, reflecting strong suppo...
Soligenix Advances Psoriasis Trial with Encouraging Patient Results, Market Potential
Soligenix is advancing its phase 2a trial of SGX302 for mild-to-moderate psoriasis, building on positive earlier data and positioning itself in the de...
Tonix Pharmaceuticals Advances TNX-2900 for Prader-Willi Syndrome Into Phase 2 Trial
The FDA has cleared Tonix Pharmaceuticals' IND application for TNX-2900, a novel intranasal oxytocin formulation for Prader-Willi syndrome, advancing ...
Quantum BioPharma Appoints Dr. Jack Antel as Clinical Advisor for MS Program
Quantum BioPharma Ltd. appointed renowned MS expert Dr. Jack Antel as clinical advisor to guide Phase 2 trials of its investigational drug Lucid-MS, a...
GeoVax to Present COVID-19 Vaccine Data at World Vaccine Congress Europe 2025
GeoVax will present interim safety and special-populations data for its GEO-CM04S1 COVID-19 vaccine in immunocompromised patients at the World Vaccine...
Annovis Bio Reports Buntanetap Reduces Inflammation and Strengthens Neuronal Health in Alzheimer’s Patients
New biomarker data from Annovis Bio’s Phase 2/3 study shows buntanetap reduces inflammatory markers and neurofilament light chain in Alzheimer’s patie...
Fifty 1 Labs Appoints Dr. Joel Gagnier as Chief Science Officer to Advance AI-Driven Health Research
Fifty 1 Labs, Inc. (OTC: FITY) has appointed Dr. Joel Gagnier as Chief Science Officer to lead AI-driven research in musculoskeletal health and person...
Lifordi Immunotherapeutics to Present New Preclinical Data on ADC LFD-200 Showing Selective Glucocorticoid Delivery Without Toxicity
Lifordi will present data at ACR 2025 showing LFD-200, an antibody drug conjugate, delivers glucocorticoids to immune cells with sustained anti-inflam...
Neutra Corp's Subsidiary Neutra Life Sciences Expands Clinical Research Footprint With New Family Medicine Partnership
Neutra Corp announces its subsidiary Neutra Life Sciences has added MediNet Family Care Clinic to its clinical trial site network, expanding capabilit...
Soligenix Closes $7.5 Million Public Offering, Extending Cash Runway Through 2026
Soligenix has closed a $7.5 million public offering, providing financial flexibility to advance its rare disease pipeline through key milestones and r...
FDA Approves First One-Minute HIV Self-Test, INSTI® HIV Self Test
The FDA has approved bioLytical's INSTI® HIV Self Test, the fastest home-use HIV test delivering accurate results in 60 seconds, advancing U.S. effort...
NanoViricides' Dual-Track Clinical Strategy for NV-387 Highlighted in Analyst Report
NanoViricides (NYSE American: NNVC) was featured in a Proactive Investors analyst report detailing its dual-track clinical development strategy for NV...
Cardio Diagnostics Highlights Molecular Precision in Coronary Heart Disease Detection
Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) addresses a critical blind spot in coronary heart disease detection by leveraging epigenetic and genet...
Quantum BioPharma Reaches Midpoint in Multiple Sclerosis Imaging Study, Early Data Shows Promise
Quantum BioPharma's collaborative imaging study with Massachusetts General Hospital has reached the halfway point in patient enrollment, with early re...